Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production

Clinical Infectious Diseases

Volumn 31, Issue 6, 2000, Pages 1338-1342

  Spittler, Andreas ^a   Razenberger, Martina ^a   Kupper, Hartmut ^c   Kaul, Martin ^c   Hackl, Werner ^b   Boltz Nitulescu, George ^a   Függer, Reinhold ^a   Roth, Erich ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c Knoll AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 6;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CLASSIFICATION; EVALUATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; PHAGOCYTOSIS; PROGNOSIS; SEPSIS;

ADULT; CYTOKINES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; PHAGOCYTOSIS; PROGNOSIS; SEPSIS;

EID: 0034573399     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317499     Document Type: Article

References (19)

1. Parrillo JE. Pathogenetic mechanism of septic shock. N Engl J Med 1993; 328:1471-7.
2. Barron RL. Pathophysiology of septic shock and implications for therapy. Clin Pharmacol 1993;12:829-45.
3. Glauser MP, Zanetti G, Baumgartner JD. Septic shock: pathogenesis. Lancet 1991;338:732-6.
4. Spooner CE, Markowitz NP, Saravolatz LD. The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 1992;62:11-7.
5. Cerami AC, Beutler B. Role of cachectin TNF in endotoxic shock and cachexia. Immunol Today 1988;9:28-31.
6. Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 1990;55:157-70.
7. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent sepsis shock during lethal bacteraemia. Nature 1987;330: 662-4.
8. Doherty GM, Lange JR, Langstein UN, et al. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 1992;149:1666-70.
9. Bone RC. Pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
10. Natanson C, Danner RL, Elin RJ, et al. Role of endotoxemia in cardiovascular dysfunction and mortality: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 1989;83:243-51.
11. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7.
12. Calandra T, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990;161:982-7.
13. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as marker of severity. Ann Surg 1992;215:356-62.
14. Hack CE, de Groot ER, Felt-Bersma RJF, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989;74:1704-10.
15. Akira S, Hirano T, Taga T, Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL 1 and TNF). FASEB J 1990;4: 2860-7.
16. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994;5:517-31.
17. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
18. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol 1994;57:1-127.
19. Moore FD Jr. Therapeutic regulation of the complement system in acute injury states. Adv Immunol 1994;56:267-99.